Circuit-specific gene therapy is knocking on the door of Parkinson’s disease

Yue-Qi Wang; Ming Yin; Zhe-Shan Guo

doi:10.24272/j.issn.2095-8137.2023.353

Volume 44 Issue 6

Nov. 2023

Turn off MathJax

Article Contents

Article Navigation > Zoological Research > 2023 > 44(6): 1152-1153

Yue-Qi Wang, Ming Yin, Zhe-Shan Guo. Circuit-specific gene therapy is knocking on the door of Parkinson’s disease. Zoological Research, 2023, 44(6): 1152-1153. doi: 10.24272/j.issn.2095-8137.2023.353

Citation:

Yue-Qi Wang, Ming Yin, Zhe-Shan Guo. Circuit-specific gene therapy is knocking on the door of Parkinson’s disease. Zoological Research, 2023, 44(6): 1152-1153. doi: 10.24272/j.issn.2095-8137.2023.353

Citation:

PDF( 1163 KB)

Circuit-specific gene therapy is knocking on the door of Parkinson’s disease

doi: 10.24272/j.issn.2095-8137.2023.353

Yue-Qi Wang^{1, 2, 3},
Ming Yin^{1, 2
,
,},
Zhe-Shan Guo^{1, 2
,
,}

1.
State Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, Hainan University, Haikou, Hainan 570228, China
2.
Key Laboratory of Biomedical Engineering of Hainan Province, One Health Institute, Hainan University, Haikou, Hainan 570228, China
3.
Shenzhen Technological Research Center for Primate Translational Medicine, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055 China

The authors declare that they have no competing interests.
Y.Q.W., M.Y., and Z.S.G. conceived and wrote the draft. Y.Q.W. generated the figure. All authors read and approved the final version of the manuscript.

Funds: This work was supported by the National Natural Science Foundation of China (32160204), Major Science and Technology Projects of Hainan Province (ZDKJ2021032), and STI 2030—Major Projects (2022ZD0208602)

More Information

Corresponding author: E-mail: ming_yin@hainanu.edu.cn; guozheshan@hainanu.edu.cn
Received Date: 2023-11-07
Accepted Date: 2023-11-15

Published Online: 2023-11-17

Publish Date: 2023-11-18

Abstract

FullText(HTML)

References(9)

References

[1]	Bloem BR, Okun MS, Klein C. 2021. Parkinson's disease. The Lancet, 397(10291): 2284−2303. doi: 10.1016/S0140-6736(21)00218-X
[2]	Chen YF, Hong ZX, Wang JY, et al. 2023. Circuit-specific gene therapy reverses core symptoms in a primate Parkinson’s disease model. Cell,doi: 10.1016/j.cell.2023.10.004.
[3]	Chen ZZ, Niu YY. 2019. Stem cell therapy for Parkinson's disease using non-human primate models. Zoological Research, 40(5): 349−357. doi: 10.24272/j.issn.2095-8137.2019.053
[4]	Kang L, Jin SL, Wang JY, et al. 2023. AAV vectors applied to the treatment of CNS disorders: clinical status and challenges. Journal of Controlled Release, 355: 458−473. doi: 10.1016/j.jconrel.2023.01.067
[5]	Li H, Su LY, Yang LX, et al. 2021a. A cynomolgus monkey with naturally occurring Parkinson's disease. National Science Review, 8(3): nwaa292. doi: 10.1093/nsr/nwaa292
[6]	Li H, Yao YG, Hu XT. 2021b. Biological implications and limitations of a cynomolgus monkey with naturally occurring Parkinson's disease. Zoological Research, 42(2): 138−140. doi: 10.24272/j.issn.2095-8137.2021.004
[7]	Roth BL. 2016. DREADDs for neuroscientists. Neuron, 89(4): 683−694. doi: 10.1016/j.neuron.2016.01.040
[8]	Volkmann J, Daniels C, Witt K. 2010. Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nature Reviews Neurology, 6(9): 487−498. doi: 10.1038/nrneurol.2010.111
[9]	Wang R, Shih LC. 2023. Parkinson's disease - current treatment. Current Opinion in Neurology, 36(4): 302−308. doi: 10.1097/WCO.0000000000001166